European Healthtech startup funding raised during Q1 2017.
In Q1 2017, 77 European Healthtech companies raised a combined €413M across 79 funding rounds, up 27.9% versus Q1 2016. UK led by capital raised, and Bpifrance was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Breath Therapeutics | Series A | Mar 2017 | €44M |
| Medlumics | Series B | Mar 2017 | €34M |
| Atlas Genetics | Series D+ | Jan 2017 | €32M |
| Pulmocide | Series B |
8 exits · €318M disclosed.
| Zur Rose | IPO | Jan 2017 | €184M |
| Europa Apotheek | Acquisition | Feb 2017 | €126M |
| Evoxx Technologies | Acquisition | Feb 2017 | €7.7M |
| Mar 2017 |
| €28M |
| Doctolib | Series C | Jan 2017 | €26M |
| Cambridge Medical Robotics | Other | Mar 2017 | €25M |
| HealthWatch | Growth/Late | Jan 2017 | €18M |
| MediSafe | Series B | Mar 2017 | €13M |
| TxCell | Growth/Late | Feb 2017 | €11M |
| Owlstone Medical | Growth/Late | Jan 2017 | €11M |
| myTomorrows | Growth/Late | Jan 2017 | €10M |
| CellProthera | Early VC | Jan 2017 | €8.3M |
| Amra | Early VC | Jan 2017 | €8.2M |
| Hemarina | Early VC | Mar 2017 | €8.0M |
| Luxendo | Series A | Jan 2017 | €8.0M |
